HL7 Terminology (THO)
5.5.0 - Publication
This page is part of the HL7 Terminology (v5.5.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Official URL: http://terminology.hl7.org/ValueSet/v3-SpecimenAdditiveEntity | Version: 3.0.0 | |||
Active as of 2014-03-26 | Responsible: Health Level Seven International | Computable Name: SpecimenAdditiveEntity | ||
Other Identifiers: urn:ietf:rfc:3986#Uniform Resource Identifier (URI)#urn:oid:2.16.840.1.113883.1.11.16042 | ||||
Copyright/Legal: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license |
Set of codes related to specimen additives
References
This value set includes codes based on the following rules:
http://terminology.hl7.org/CodeSystem/v3-EntityCode
where concept is-a _SpecimenAdditiveEntityThis value set excludes codes based on the following rules:
http://terminology.hl7.org/CodeSystem/v3-EntityCode
Code | Display | Definition |
_SpecimenAdditiveEntity | SpecimenAdditiveEntity | Set of codes related to specimen additives |
Expansion based on codesystem EntityCode v3.0.0 (CodeSystem)
This value set contains 54 concepts.
Code | System | Display | Definition |
ACDA | http://terminology.hl7.org/CodeSystem/v3-EntityCode | ACD Solution A | ACD Solution A of trisodium citrate, 22.0g/L; citric acid, 8.0 g/L; and dextrose 24.5 g/L. Used in Blood banking and histocompatibilty testing |
ACDB | http://terminology.hl7.org/CodeSystem/v3-EntityCode | ACD Solution B | ACD Solution B of trisodium citrate, 13.2g/L; citric acid, 4.8 g/L; and dextrose 14.7 g/L. Used in Blood banking and histocompatibilty testing. |
ACET | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Acetic Acid | 50% V/V acetic acid in water. Used as a urine preservative |
AMIES | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Amies transport medium | Sodium Chloride 3.0g, Potassium Chloride 0.2g, Calcium Chloride 0.1g, Magnesium Chloride 0.1g, Monopotassium Phosphate 0.2g, Disodium Phosphate 1.15g, Sodium Thiogly collate 1.0g, Distilled Water 1 liter |
BACTM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Bacterial Transport medium | Any medium used to maintain bacterial viability (e.g. Stuart's, Cary-Blair, Amies) |
BF10 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Buffered 10% formalin | Formaldehyde 4% w/v; methyl alcohol 1% w/v; phosphate buffering salts. Tissue preservative |
BOR | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Boric Acid | Powdered boric acid (usually 10 g) added to 24-hour urine collections as a preservative. |
BOUIN | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Bouin's solution | Picric acid, saturated aqueous solution (750.0 ml), 37-40% formalin (250.0 ml), glacial acetic acid (50.0 ml). Tissue preservative. |
BSKM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Buffered skim milk | 50% skim milk in 0.01 M phosphate-buffered saline. Maintain virus viability |
C32 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | 3.2% Citrate | A 3.2% solution of Sodium Citrate in water. Used as a blood preservative |
C38 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | 3.8% Citrate | A 3.8% solution of Sodium Citrate in water. Used as a blood preservative |
CARS | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Carson's Modified 10% formalin | A modification of buffered 10% formalin used as a general tissue preservative. |
CARY | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Cary Blair Medium | Sodium Thioglycollate 1.5 g, Disodium Hydrogen Phosphate 1.1 g, Sodium Chloride 5.0 g, Calcium Chloride 0.09 g, Agar 5.0 g, per Liter of Water |
CHLTM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Chlamydia transport medium | Any of a number of non-nutritive buffered media used to maintain Chlamydia viability during transportation to the laboratory |
CTAD | http://terminology.hl7.org/CodeSystem/v3-EntityCode | CTAD | Buffered tri-sodium citrate solution with theophylline, adenosine and dipyridamole |
EDTK15 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Potassium/K EDTA 15% | Potassium EDTA 15% solution in water |
EDTK75 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Potassium/K EDTA 7.5% | Potassium EDTA 7.5% solution in water |
EDTN | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Sodium/Na EDTA | Sodium fluoride and Disodium EDTA |
ENT | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Enteric bacteria transport medium | Any of a number of non-nutritive buffered media used to maintain enteric bacterial viability during transportation to the laboratory |
F10 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | 10% Formalin | A 10% v/v solution in water of formalin( a 37% solution of formaldehyde and water). Used for tissue preservation. |
FDP | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Thrombin NIH; soybean trypsin inhibitor | Thrombin plus soybean trypsin inhibitor. For use in identifying fibrn degredation products. |
FL10 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Sodium Fluoride, 10mg | Sodium fluoride, 10mg added as a urine preservative. |
FL100 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Sodium Fluoride, 100mg | Sodium fluoride, 100mg added as a urine preservative. |
HCL6 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | 6N HCL | A solution of HCl containing 6moles of hydrogen ion/L. Used as a Urine Preservative. |
HEPA | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Ammonium heparin | Ammonium heparin |
HEPL | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Lithium/Li Heparin | Lithium heparin salt |
HEPN | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Sodium/Na Heparin | Sodium heparin salt |
HNO3 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Nitric Acid | 6N Nitric acid used to preserve urine for heavy metal analysis. |
JKM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Jones Kendrick Medium | A transport medium formulated to maintain Bordetella pertussis viability. |
KARN | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Karnovsky's fixative | 5% Glutaraldehyde, 4% Formaldehyde in 0.08M buffer. Tissue preservation |
KOX | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Potassium Oxalate | Potassium oxalate and sodium fluoride in a 1.25:1 ratio |
LIA | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Lithium iodoacetate | Iodoacetate lithium salt |
M4 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | M4 | Modified Hank's balanced salt solution supplemented with bovine serum albumin, gelatin, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with HEPES buffer. Phenol red is used to indicate pH. Vancomycin, Amphotericin B and Colistin are used to |
M4RT | http://terminology.hl7.org/CodeSystem/v3-EntityCode | M4-RT | Modified Hank's balanced salt solution supplemented with bovine serum albumin, gelatin, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with Hepes buffer. Phenol red is used to indicate pH. Gentamicin and amphotericin B are used to inhibit c |
M5 | http://terminology.hl7.org/CodeSystem/v3-EntityCode | M5 | Modified Hank's balanced salt solution supplemented with protein stabilizers, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with Hepes buffer. Phenol red is used to indicate pH. Vancomycin, Amphotericin B and Colistin are used to inhibit c |
MICHTM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Michel's transport medium | 1M potassium citrate, pH 7.0 2.5 ml, 0.1M magnesium sulfate 5.0 ml, 0.1M N-ethyl malemide 5.0 ml, dH2O 87.5 ml, ammonium sulfate 55gm. Preserve antigens for Immunofluorescence procedures |
MMDTM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | MMD transport medium | A buffered medium with ammonium sulfate added to preserve antigens for Immunofluorescence procedures |
NAF | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Sodium Fluoride | Sodium fluoride |
NONE | http://terminology.hl7.org/CodeSystem/v3-EntityCode | None | No additive. Specifically identifes the specimen as having no additives. |
PAGE | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Page's Saline | 0.12 g NaCl, 0.004 g MgSO, 0.004 g, CaCl, 0.142 g Na2HPO4 and 0.136 g KH2PO4 per liter of distilled water. Maintain Acanthaoemba viability. |
PHENOL | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Phenol | Phenol. Urine preservative |
PVA | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Polyvinylalcohol | Polyvinyl alcohol |
RLM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Reagan Lowe Medium | A transport medium formulated to maintain Bordetella pertussis viability. |
SILICA | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Siliceous earth | Diatomaceous earth. For glucose determination blood samples |
SPS | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride | Sodium polyanethol sulfonate in saline. Anticomplementary and antiphagocytic properties. Used in blood culture collection. |
SST | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Serum Separator Tube | Polymer separator gel with clot activator |
STUTM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Stuart transport medium | Sodium Glycerophosphate 10.0g, Calcium Chloride 0.1g, Mercaptoacetic Acid 1.0ml, Distilled Water 1 liter |
THROM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Thrombin | Thrombin. Accelerates clotting. |
THYMOL | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Thymol | 2-Isopropyl-5-methyl phenol. A preservative for 24 Hr Urine samples |
THYO | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Thyoglycolate broth | A nutritive medium with a reducing agent (sodium thioglycolate) which, due to a chemical reaction, removes oxygen from the broth. |
TOLU | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Toluene | Also known as Methylbenzene; Toluol; Phenylmethane. A preservative for 24 Hr Urine samples |
URETM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Ureaplasma transport medium | A buffered salt solution with antifungal agents added for the collection and transport of Ureaplasma specimens. |
VIRTM | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Viral Transport medium | Sucrose 74.6g, Potassium hydrogenphosphate 0.52g, L-glutamic acid 0.72g, Bovine serum albumin 5.0g, Gentamicin 50mg, Potassium dihydrogenphosphate 1.25g, L-15 medium 9.9L, Water to 10L. Maintain Virus viability. |
WEST | http://terminology.hl7.org/CodeSystem/v3-EntityCode | Buffered Citrate | 3.8% Citrate buffered to a pH of 5.5 for Westergren Sedimentation Rate |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |
History
Date | Action | Custodian | Author | Comment |
2023-11-14 | revise | TSMG | Marc Duteau | Add standard copyright and contact to internal content; up-476 |
2022-10-18 | revise | TSMG | Marc Duteau | Fixing missing metadata; up-349 |
2020-05-06 | revise | Vocabulary WG | Ted Klein | Migrated to the UTG maintenance environment and publishing tooling. |
2014-03-26 | revise | 2014T1_2014-03-26_001283 (RIM release ID) | Vocabulary (Woody Beeler) (no record of original request) | Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 |